| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 2 Jan 25 | XLO Xilio Therapeutics | Common stock | Sell | Dispose S | No | Yes | 0.9837 | 6,954 | 6.84 k | 12,421 |
| 1 Jan 25 | XLO Xilio Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 19,375 | 0.00 | 19,375 |
| 1 Jan 25 | XLO Xilio Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.955 | 251,000 | 239.71 k | 251,000 |
| 1 Jan 25 | XLO Xilio Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 19,375 | 0.00 | 58,125 |
| 3 Aug 24 | XLO Xilio Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.895 | 52,000 | 46.54 k | 52,000 |
| 1 May 24 | XLO Xilio Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.08 | 208,000 | 224.64 k | 208,000 |
| 1 Jan 24 | XLO Xilio Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 77,500 | 0.00 | 77,500 |
| 16 Aug 23 | XLO Xilio Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.785 | 300,000 | 835.50 k | 300,000 |
